NEWS XTRA
COURT ADMITS NINE EXHIBITS IN MALAMI’S MONEY LAUNDERING TRIAL
A Federal High Court in Abuja has admitted nine documentary exhibits against former Attorney-General of the Federation and Minister of Justice, Abubakar Malami, his wife Hajia Bashir Asabe, and his son, Abubakar Abdulaziz Malami, in an ongoing alleged money laundering case.
Justice Joyce Abdulmalik admitted the documents on Monday after they were tendered by the Economic and Financial Crimes Commission through its fourth prosecution witness.
The EFCC is prosecuting the defendants on an amended 16-count charge involving conspiracy, procuring, disguising, concealing, and laundering alleged unlawful proceeds totalling ₦8.71 billion.
According to the anti-graft agency, the offences violate provisions of the Money Laundering (Prevention and Prohibition) Act, 2022.
The exhibits, mainly banking records, were presented through Zenith Bank compliance officer, Mashelia Arhyel Bata.
The witness told the court that the bank responded to an EFCC request by providing electronic and hard copies of account documents linked to the defendants and several companies.
The companies listed include Rayhaan Hotels Limited, Rayhaan Bustan Agro Allied Limited, Nashab Limited, Golden Age Global Ventures, and Rahamaniyya Properties Limited.
The court admitted the documents, dated between July 19, 2024 and March 12, 2026, as Exhibits D1 to D9.
During testimony, the witness stated that one of the accounts recorded credits of ₦383.6 million between 2016 and 2023, while another ₦560.5 million was credited between 2012 and 2015.
He also identified major inflows including ₦194.7 million from New Horizons Limited in November 2020 and ₦622.5 million from Rayhaan Bustan Agro Allied Limited in June 2022.
Additional credits of ₦250 million each in July 2022 and ₦500 million in December 2022 were also linked to corporate entities.
Defence counsel requested more time to study the nine exhibits before cross-examination.
The court granted the request and adjourned the matter until May 13, 2026, for continuation of trial.
"This represents a significant development in our ongoing coverage of current events."— Editorial Board